EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program

Antonio Carotenuto, Dimitris Naoumis, Vincenzo Brescia Morra, Evangelos Kouremenos, Suzannah Hetherington, Sophie Arnould, Virginia de Las Heras

Degenerative Neurological and Neuromuscular Disease · 2026-04 · Volume 16 · 1-12

DOI: 10.2147/dnnd.s540207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Degenerative Neurological and Neuromuscular Disease, 2026-04. Verfasst von Antonio Carotenuto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University …. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

EDSScognitive functionmanaged access programreal-world datasecondary progressive multiple sclerosissiponimod

Autor:innen und Institutionen

  • Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Naples, Italy.
  • 251 Airforce General Hospital, Athens, Greece.
  • Novartis Ireland Limited, Dublin, Ireland.
  • Novartis Pharma AG, Basel, Switzerland.

Zitieren

APA

Carotenuto, A., Naoumis, D., Brescia Morra, V., Kouremenos, E., Hetherington, S., Arnould, S., & Heras, V. L. (2026). Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program. Degenerative Neurological and Neuromuscular Disease, Volume 16, 1-12. https://doi.org/10.2147/dnnd.s540207

Vancouver

Carotenuto A, Naoumis D, Brescia Morra V, Kouremenos E, Hetherington S, Arnould S, et al. Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program. Degenerative Neurological and Neuromuscular Disease. 2026;Volume 16:1-12. doi:10.2147/dnnd.s540207

BibTeX
@article{Carotenuto2026,
  author = {Carotenuto, Antonio and Naoumis, Dimitris and Brescia Morra, Vincenzo and Kouremenos, Evangelos and Hetherington, Suzannah and Arnould, Sophie and Heras, Virginia de Las},
  title = {Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program},
  journal = {Degenerative Neurological and Neuromuscular Disease},
  year = {2026},
  volume = {Volume 16},
  pages = {1--12},
  doi = {10.2147/dnnd.s540207}
}
Kostenlos starten →